Record Display for the EPA National Library Catalog

RECORD NUMBER: 12 OF 212

OLS Field Name OLS Field Data
Main Title Antiviral Strategies [electronic resource] /
Type EBOOK
Author Kräusslich, Hans-Georg.
Other Authors
Author Title of a Work
Bartenschlager, Ralf.
Publisher Springer Berlin Heidelberg,
Year Published 2009
Call Number RM1-950
ISBN 9783540790860
Subjects Medicine. ; Gene therapy. ; Drug interactions. ; Toxicology. ; Pharmaceutical technology. ; Medical virology.
Internet Access
Description Access URL
http://dx.doi.org/10.1007/978-3-540-79086-0
Collation online resource.
Notes
Due to license restrictions, this resource is available to EPA employees and authorized contractors only
Contents Notes
Antiviral Strategies -- Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus -- Antiviral Agents Acting as DNA or RNA Chain Terminators -- Viral Protease Inhibitors -- Anti-Influenza Drugs: The Development of Sialidase Inhibitors -- Other Inhibitors of Viral Enzymes and Functions -- Inhibitors of Viral Entry -- Interferons and Their Use in Persistent Viral Infections -- Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses -- Antiviral Gene Therapy -- Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases -- Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection -- Socio-Economic Impact of Antiviral Intervention. A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost effectiveness. Individual chapters address in more detail all available drug classes and outline new approaches currently under development.